Startups
2025
VIOLET PHARMACEUTICALS SLVisibility to Immuno-Oncology & Lymphocyte Enhancing Therapies
Address
Carrer del Doctor Aiguader 88, 08003 Barcelona, Spain
CERCA ownership
Barcelona, Spain
1992
Hospital del Mar Research Institute (HMRIB)
CERCA Center Contact
IÁ
Ismael Ávila
Hospital del Mar Research Institute (HMRIB)Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
VIOLET Pharmaceuticals is a preclinical stage biopharma company developing a First-in-Class mRNA therapy against metastatic cancers. The company develops nanotherapies improving immunotherapies’ efficiency and approved indications (e.g. Immune Checkpoints Inhibitors (ICI)) by increasing the whole Antigen Presentation Machinery (APM) in tumor cells.
Product description
Our LCOR mRNA technology is backed by Top-Notch science published in leading journals such as Nature Cell Biology and Nature Cancer, and has a strong IP position (3 patents). We achieved radical complete responses of our LCOR mRNA NanoTherapy in combination with ICI in several breast cancer tumors and metastasis models.
LCOR specifically modulates the whole APM which determines immune detection
LCOR specifically modulates the whole APM which determines immune detection